ARDX Q1 2026 Earnings EPS Misses Estimates by 142 Revenue Not Disclosed GENB Q1 2026 Earnings Wider Loss Stings but Pipeline Progress Lifts Shares LUNR Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent OGI Q1 2026 Earnings Narrowerthanexpected loss signals improving cost discipline Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs DECK Q1 2026 Earnings EPS Surprises 13 Above Estimates as Footwear Momentum Persists